Hyaluronic acid treatment (viscosupplementation) for OA of the knee

Bulletin on the Rheumatic Diseases

Volumn 47, Issue 7, 1998, Pages 4-7

  Cohen, Marc D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; HYALURONIC ACID; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIA; ARTHROSCOPIC SURGERY; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HUMAN; KNEE ARTHROPLASTY; KNEE OSTEOARTHRITIS; LUBRICATION; MUSCLE STRENGTH; PHYSIOTHERAPY; REVIEW; SYNOVIAL FLUID; VISCOELASTICITY; WEIGHT REDUCTION;

HUMANS; HYALURONIC ACID; OSTEOARTHRITIS, KNEE;

EID: 0031796989     PISSN: 00075248     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Pharmacy and therapeutics review: The formulary. 571-580, Dec 1997.
2. Balazs EA, Denlinger JL: Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol 20(Suppl 39):3-9, 1993.
3. Pelletier JP, Martel-Pelletier J: The pathophysiology of osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol 20(Suppl 39):19-24, 1993.
4. Aviad AD, Houpt JB: The molecular weight of therapeutic hyaluronan (sodium hyaluronate): how significant is it? J Rheumatol 21:297-301, 1994.
5. Peyron JG: Intra-articular hyaluronan injections in the treatment of osteoarthritis: state-of-the-art review. J Rheumatol 20 (Suppl 39):105, 1993.
6. Jones AC, Pattrick M, Doherty S, Doherty M: Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthritis Cartilage 3:269-73, 1995.
7. Dougados M, Nguyen M, Listrat V, Amor B: High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1-year placebo-controlled trial. Osteoarthritis Cartilage 1:97-103, 1993.
8. Henderson EB, Smith EC, Pegley F, Blake DR: Intra-articular injection of 750 kD hyaluronan in the treatment of osteoarthritis: a randomised single centre double-blind placebo-controlled trial of 91 patients demonstrating lack of efficacy: Ann Rheum Dis 53:529-34, 1994.
9. Listrat V, AyralX, Patarnello F, et al: Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan®) in osteoarthritis of the knee. Osteoarthritis Cartilage 5:153-60, 1997.
10. Lussier A, Cividino AA, McFarlane CA, et al: Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 23:1579-85, 1996.
11. Adams ME: An analysis of clinical studies of the use of cross linked hyaluronan, hylan, in the treatment of osteoarthritis. J Rheumatol 20(Suppl 39):16-8, 1993.
12. Adams ME, Atkinson MH, Lussier AJ, et al: The role of viscosupplementation with hylan G-F 20 (Synvisc®) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F20 alone, hylan G-F 20 with non-steroidal antiinflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthritis Cartilage 3:213-26, 1995.
13. Lohmander LS, Dalen N, Englund G, et al: Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: A randomised, double blind, placebo controlled multicentre trial. Ann Rheum Dis 55:424-31, 1995.
14. Puttick MPE, Wade JP, Chalmers A, Connell DG, Rangno KK, et al: Acute local reactions after intra-articular hylan for osteoarthritis of the knee. J Rheumatol 22:1311-4, 1995.
15. Smith GN Jr, Myers SL, Brandt KD, Mickler EA: Effect of intraarticular hyaluronan injection in experimental canine osteoarthritis. Arthritis Rheum 41:976-985, 1998.